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Abstract
Background: Asthma is a chronic inflammatory airway disease characterized by reversible obstruction, inflammation
and hyperresponsiveness to different stimulus. Aerobic and breathing exercises have been demonstrated to benefit
asthmatic patients; however, there is no evidence comparing the effectiveness of these treatments.
Methods/design: This is a prospective, comparative, blinded, and randomized clinical trial with 2 groups that will
receive distinct interventions. Forty-eight asthmatic adults with optimized medical treatment will be randomly divided
into either aerobic (AG) or breathing exercises (BG). Patients will perform breathing or aerobic exercise twice a week for
3 months, totalizing 24 sessions of 40 minutes each. Before intervention, both groups will complete an educational
program consisting of 2 educational classes. Before and after interventions, the following parameters will be quantified:
clinical control (main outcome), health related quality of life, levels of anxiety and depression, daily living physical
activity and maximal exercise capacity (secondary outcome). Hyperventilation syndrome symptoms, autonomic
nervous imbalance, thoracoabdominal kinematics, inflammatory cells in the sputum, fraction of exhaled nitric
oxide (FENO) and systemic inflammatory cytokines will also be evaluated as possible mechanisms to explain the
benefits of both interventions.
Discussion: Although the benefits of breathing and aerobic exercises have been extensively studied, the
comparison between both has never been investigated. Furthermore, the findings of our results will allow us to
understand its application and suitability to patients that will have more benefits for every intervention optimizing
its effect.
Trial registration: Clinicaltrials.gov; Identifier: NCT02065258.
Keywords: Physiotherapy, Breathing exercise, Aerobic exercise, Symptoms, Asthma control
Background
Asthma is a chronic inflammatory disorder of the airways
that involves many cells and cellular elements. The disease
severity can be classified as intermittent or persistent
(mild, moderate or severe), and this classification con-
siders the presence of diurnal and nocturnal symptoms,
necessity of medication, frequency of exacerbation,
physical activity limitations and pulmonary function
[1]. The chronic inflammation is associated with airway
hyperresponsiveness and airflow obstruction, which
lead to recurrent episodes of wheezing, breathlessness,
chest tightness and coughing, particularly at night or in
the early morning. All of these symptoms deteriorate in
the patient’s quality of life and psychological well-being
and restrict daily living physical activities (DLPA) [2].
The asthma symptoms experienced during DLPA or
the fear of triggering symptoms may keep asthmatic sub-
jects from engaging in physical exercise, and the patients
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tend to be less physically active and less conditioned
than healthy individuals [3]. In addition, asthmatic
patients have higher levels of anxiety and depression that
have been shown to be associated with an increased
number of exacerbations [4] and the diagnosis of severe
asthma [5]. These psychosocial disorders can modify the
respiratory breathing pattern, which leads to irregular
breathing, frequent sighing, and predominant thoracic
breathing [6]. These irregular breathing patterns increase
the number of respiratory (breathlessness, chest tight-
ness and pain) and non-respiratory symptoms (anxiety,
dizziness and fatigue) [7].
Asthma does not have a cure but its clinical manifesta-
tions can be controlled with the appropriate treatment.
The goal for asthma treatment is to achieve and maintain
asthma control, and the treatment is based on medication
(controllers and relievers). Clinical control is defined as an
effective management of the characteristics of the disease,
which include control of the following symptoms: noc-
turnal awakening, reliever use and activity limitation [8].
However, recent studies have also shown that non-
medicinal treatments are important adjuvants in asthma
treatment, and the main techniques used worldwide are
aerobic [9] and breathing exercises [10].
There is evidence suggesting that aerobic training im-
proves fitness and health related quality of life (HRQoL)
[11]. Additionally, aerobic training reduces psychosocial
distress [2], exercise-induced bronchoconstriction [12]
and corticosteroid consumption [13], exacerbation epi-
sodes and asthma symptoms [13]. Moreover, breathing
exercises have been shown to improve HRQoL [14] and
expiratory peak flow values [15]. Breathing exercises also
reduce the levels of anxiety and depression [16], asthma
symptoms [17], the use of relief medication [14], exacer-
bation episodes and airway hyperresponsiveness [18].
The research questions were:
1. Which exercise intervention is more effective to
improve clinical control in patients with moderate
and severe asthma?
2. Which are the mechanisms involved to improve
clinical control in both interventions?
Method
Design
This trial was designed as a prospective, comparative,
blinded, and randomized clinical trial with 2 groups that
will receive distinct interventions. See the study design
in Figure 1.
Participants, therapists, centers
Study setting
Patients will be recruited from an outpatient clinic that
assists moderate and severe asthmatic patients in an
University Hospital. The Clinics Hospital Ethics Com-
mittee approved the study (0097/10). All participants
gave written informed consent before data collection
began.
Allocation and randomization
Eligible patients will be randomized to either breathing
or aerobic exercise interventions. The randomization
schedule was computer-generated by the chief investiga-
tor who will not be involved in the recruitment or treat-
ment of the patients.
Eligibility criteria
The Hospital Ethics Committee approved the study and
patients must provide written informed consent before
any study procedures be performed. Asthma diagnosis
and treatment will be based on the guidelines of the
Global Initiative for Asthma [19].
Inclusion criteria
Age between 25 and 65 years-old; both genders; body
mass index (BMI) <35 Kg/m2; sedentary (currently
doing < 60 minutes of structured/planned physical
activity per week); medical treatment for at least
6 months; and clinically stable (i.e., no crises or
changes in medication for ≥30 days).
Exclusion criteria
Smokers; participants in another research protocol; pa-
tients that are incapable of exercising; unable to under-
stand any questionnaire; any other medical condition
that confers greater morbidity than asthma (e.g., active
cancer) which will be confirmed by physician review;
currently pregnant.
Intervention
Educational program
Before the interventions, both groups will complete an
educational program that consists of 2 classes performed
once a week and lasting 2 hours each. Presentations and
group discussions will include information about asthma
pathophysiology, medication skills, self-monitoring tech-
niques, and environmental control and avoidance strat-
egies according to previous studies [2] and asthma
guidelines [19].
Aerobic training program
It will be performed on a treadmill with an initial inten-
sity of 60% and reaching a maximum intensity of 80% of
the predicted heart rate during training. The intensity
values will be calculated using Karvonen’s formula [20]
(1957). Exercise intensity will be increased if the patient
does not experience an increase in asthma symptoms
during the exercise for 2 consecutive training days.
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Before and after every session, patients will perform a
peak expiratory flow test. If these values are lower than
70% of the patient’s maximum value, then the patient
will be advised to use the rescue dose of a bronchodila-
tor prescribed their physician. All of the aerobic training
details have been previously described elsewhere [13].
Breathing exercise
Breathing exercise will be based on Yoga’s breathing
techniques [21] and will focus on stimulating nasal and
diaphragmatic breathing, increasing the expiratory time,
slowing the respiratory flow and regulating the breathing
rhythm. Breathing exercises will be divided into 3 phases
(lasting one month each) with an intensity progression
every 8 sessions (Table 1).
All participants will be required to maintain their nor-
mal medical regimens during the interventions.
Outcome measures
Primary outcome
The asthma control questionnaire (ACQ) [22] will be
used to assess asthma control. We will compare the dif-
ferences between the 2 interventions in the absolute
change in asthma control post-intervention. This ques-
tionnaire is validated to measure asthma control in adult
patients and have been validated to Brazilian Portuguese
[23]. ACQ is a simple instrument and is easy to use that
quantifies the following asthma symptoms: nocturnal
and morning symptoms, limitation of daily activities,
dyspnea and wheezing, and the use of medication
(short-acting β2-agonist). Patient’s will be scored on
a scale ranging from 0 to 6 (0 = without limitation and
6 =maximum limitation). The clinical score of forced
expiratory volume (% of predicted, pre-bronchodilator)
will be scored on similar scale. The items will be calcu-
lated, and the scores of the ACQ will be the average
from 7 items between 0 (fully controlled) and 6 (se-
verely uncontrolled). The cutoff will be adopted from
previously developed studies, considering controlled
(ACQ <0.75 points), not well controlled or poorly con-
trolled asthma (ACQ > 1.5 points). A clinically effective
treatment results in a 0.5 point decrease in the score
after the intervention [24].
Secondary outcomes
Psychosocial morbidity The asthma quality of life
questionnaire (AQLQ) [25] and the hospital anxiety and
depression (HAD) scale [26] will be used to assess
psychosocial morbidity. We will compare the differences
between both interventions in the absolute values.
AQLQ is a questionnaire divided into the following 4
domains: physical limitation, frequency of symptoms,
socioeconomic, and psychosocial. Each domain has a
maximum score of 33, 6, 11, and 7 points, respectively
Included pacients
Evaluation
Educational program
Class 1
•Pathophysiology
•Medication skills
•Self-monitoring techniques
Class 2
•Environmental control
•Avoidance strategies
•Peak flow meter
Visit 1
•Clinical control
•Anxiety / depression
•Hyperventilation Syndrome
•Pulmonary and sistemic inflamation 
•Daily life physical activity
Visit 2
•Pulmonary function
•Maximal exercise capacity
•Thoracoabdominal kinematics
•Autonomic control
Randomization
Aerobic group Breathing group24 sessions
Revaluation
Figure 1 Study flow chart: after inclusion, patients will be evaluated twice. In visit one clinical control, pulmonary and systemic inflammation
and psychosocial variables will be measured and in visit two pulmonary function, maximal exercise capacity, thoracoabdominal kinematics and
autonomic control will be assessed; afterwards subjects will begin the educational program, consisting of two classes: one related to the disease and
skills concerning medication and self-monitoring, and other related to control of external factors and peak flow meter usage. Only then, subjects will
be randomized into aerobic or breathing group for 24 sessions, after which they will be revaluated.
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Table 1 Breathing exercise program
1st phase
Exercise Duration Repetition
Lying position
Raise right arm, left arm and then both, stretching the intercostal muscles 20 s 2
Pull right knee, left knee and then both, stretching paraspinal muscles 20 s 2
Turn hip to the side, keeping your shoulders flat on the mat. One hand holds the knee while
lifting up the other arm
20 s 1 each side
Lateral decubitus, one arm supporting the head and other remains draped over the body.
Inspiring, rise the arm above the head, eeturning to the starting position, at expiration
1 breath 4 each side
Keep an outstretched arm, while making three deep breaths, return. 20 s 1 each side
Inspire holding knees and pull them toward your chest as you exhale 1 breath 4
With the body length, holding the head with hands and take them towards the chest 20 s 1
Sitting
With your legs extended and stretch the posterior muscles, leading arms outstretched to the feet 20 s 1
Stretch intercostal muscles and obliques, and raising arm laterally flexing the trunk 20 s 2 each side
Introduction to the breathing exercise with hands on abdomen and the diaphragmatic stimulation
with active expiration
1 breath 10
Kapalabhati - quick expirations generated by vigorous contraction of the rectus abdominis 1 breath 3 series of 30
With your legs extended and stretch the posterior muscles, leading arms outstretched to the feet 20 s 1
2nd phase
Exercise Duration Repetition
Lying position
Raise right arm, left arm and then both, stretching the intercostal muscles 20 s 1
Pull right knee, left knee and then both, stretching paraspinal muscles 20 s 1
Lateral decubitus, one arm supporting the head and other remains draped over the body. Inspiring,
rise the arm above the head, returning to the starting position, at expiration
1 breath 4 each side
Keep an outstretched arm, while making three deep breaths, return. 20 s 1 each side
Boat adapted: feet flat, knees bent and hands on his thigh, inhale deeply and take hands toward the
knees contracting the abdomen
1 breath 4
Inspire holding knees and pull them toward your chest as you exhale 1 breath 4
Preparation Uddhiyana: arms along the body raise the arms in inspiration, expiration returns 1 breath 4
Preparation Uddhiana: actively inhale and exhale, and apnea raise and lower arms 5 s 4
Sitting
With your legs extended and stretch the posterior muscles, leading arms outstretched to the feet 20 s 1
Preparation Uddhiyana: raise the arms sideways in inspiration and return in expiration 1 breath 4
Preparation Uddhiana: actively inhale and exhale, and apnea raise and lower arms 5 s 4
Uddhiyana Bandha: complete expiration followed by inspiratory effort in the presence of apnea 5 s 1
Uddhiyana Bandha + Kapalabhati 1 breath 3 series of 1 and 45
With your legs extended and stretch the posterior muscles, leading arms outstretched to the feet 20 s 1
3rd phase
Exercise Duration Repetition
Lying position
Raise right arm, left arm and then both, stretching the intercostal muscles 20 s 1
Pull right knee, left knee and then both, stretching paraspinal muscles 20 s 1
Lateral decubitus, one arm supporting the head and other remains draped over the body.
Inspiring, rise the arm above the head, returning to the starting position, at expiration
1 breath 4 each side
Keep an outstretched arm, while making three deep breaths, return. 20 s 1 each side
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that will be converted into percentages, where higher
scores represent better HRQoL. The HAD has 14 items
divided into 2 subscales (7 for anxiety (HAD-A) and 7
for depression (HAD-D)). For each item, there are 4
alternatives, ranging in score from 0 to 3. The sum of
each subscale score ranges from 0 to 21. The cutoff
value for anxiety and depression is 8 and 9, respectively.
Daily living physical activity (DLPA) An accelerometer
(Power Walker SW 610, Japan) will quantify the absolute
change in DLPA. The accelerometer records the total
daily number of steps, the number of steps performed at
moderate intensity (≥110 steps per minute) and the time
spent during DLPA. The assessment will be performed
over a period of 7 days, and the DLPA will be quantified
before and after the interventions. The accelerometer
automatically records the total number of steps during
the 7 days, and each patient will record their amount of
moderate intensity DLPA in a dairy. The accelerometer
will be used to average the number of steps performed
during the 5 day period (disregarding the first and last
days) [27].
Maximal exercise capacity Shuttle walking test [28]
will assess exercise capacity and it will compare the
absolute change in maximal exercise capacity post-
intervention. Cones set up in a corridor will demarcate
10 meters, and the patients will be asked to walk around
the cones at a speed pre-determined by sound signals.
The sound signals indicate the moment when the patient
must round the cone, and the speed increases at a rate
of 0.6 km/h per minute. The total protocol consists of
12 stages, and the test can be discontinued by the indi-
vidual or the therapist if the patient is unable to main-
tain the speed required to complete the stage (distance
greater than 0.5 m from the cone). The test will be dis-
continued if the patient present chest pain, intolerable
dyspnea, dizziness, cramps, leg pain or pallor. Patient’s
heart and respiratory rates, blood pressure, dyspnea and
leg fatigue will be measured before and after the test.
The scale of perceived exertion [29] will be used to
measure dyspnea and leg fatigue.
Pulmonary function It will be evaluated using spirom-
etry (SensorMedics 229; SensorMedics Corp; USA) be-
fore and after the inhalation of 200 mg of salbutamol.
Technical procedures of spirometry will be performed
as recommended by the American Thoracic Society and
European Respiratory Society [30]. Predicted normal
values will be used as proposed by Pereira et al., [31].
An increase of 12% and 200-mL in FEV1 (from baseline)
will be characterized as a positive response to the
bronchodilator.
Other notable outcomes – possible mechanisms
Hyperventilation syndrome symptoms Nijmegen ques-
tionnaire will be used to assess hyperventilation symp-
toms. We will compare the differences between the 2
treatments in the absolute change in hyperventilation
symptoms post-intervention. The Nijmegen question-
naire is composed of 16 questions that quantify abnor-
mal breathing; (each question range in scale from 0
(never) to 4 (very often)). A total score of ≥23 establishes
hyperventilation syndrome with a sensitivity of 91% and
a specificity of 95% [32].
Autonomic nervous control Patient’s heart rate vari-
ability (HRV) will be assessed at rest pre and post-
intervention by a heart rate monitor (Polar S810i,
Finland) as previously described [33] and data will be re-
corded and immediately transmitted to the computer for
analysis using the Polar Precision Performance software
(release 3.00, Kempele, Finland). HRV parameters will
be analyzed according to the components of low fre-
quency (LF), high frequency (HF), LF/HF ratio, standard
deviation of the differences between adjacent normal RR
intervals (RMSSD) after Fourier transformation and
noise filtering through the program Kubios HRV Ana-
lysis Software version 2.0 (Kuopio, Finland). Data will be
recorded in a 5 minutes interval.
Table 1 Breathing exercise program (Continued)
Boat adapted: feet flat, knees bent and hands on his thigh, inhale deeply and take hands toward
the knees contracting the abdomen
1 breath 4
Inspire holding knees and pull them toward your chest as you exhale 1 breath 4
Sitting
With your legs extended and stretch the posterior muscles, leading arms outstretched to the feet 20 s 1
Uddhiyana Bandha + Kapalabhati 5 s and 1 breath 2 series of 1 and 60
Surya bedhana: inhale through the right nostril, take head towards the chest in apnea returns to
the starting position and exhale through the left nostril.
5 s 1 each side
Surya bedhana + Kapalabhati 5 s and 1 breath 2 series of 1 and 70
With your legs extended and stretch the posterior muscles, leading arms outstretched to the feet 20 s 1
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Thoracoabdominal kinematics It will be evaluated
using optoelectronic plethysmography (OEP System,
BTS, Italy), as previously described [34]. Video is
recorded with 8 solid-state charge-coupled cameras op-
erating at 100 frames per second and synchronized with
an infrared flashing light-emitting diode. Four cameras
will be positioned in front of the subject and four
behind. Eighty-nine retro-reflective markers will be
placed on the anterior and posterior sides of the trunk
according to the protocol previously described [35]. A
three-dimensional calibration of the equipment will be
performed, based on the manufacturer’s recommenda-
tions. The assessment will be performed with the subject
seated on a chair without back support and patients will
be requested to perform 8 quiet breaths followed by 8
deep breaths guided by blinded therapist. The average of
6 homogeneous respiratory cycles will be used for the
data analysis. The chest wall volumes and inspiratory
muscular activity will be assessed concurrently. The
following variables will be measured: total chest wall and
compartmental volumes; time variables and thoracoab-
dominal asynchrony; activity of the sternocleidomastoid,
and external superior and inferior intercostal muscles by
surface electromyography (EMG BTS, Italy).
Airway inflammation It will be quantified in collected
sputum samples and exhaled fraction of nitric oxide
(FENO). Before the sputum collection, subjects will be
advised to blow their nose and rinse their mouth with
water and swallow it to reduce contamination of the
sputum specimen with postnasal drip and saliva. Then,
patients will inhale 400 μg of salbutamol followed by a
3% hypertonic saline solution inhaled over 15 min using
an ultrasonic nebulizer with an output of 2.4 mL.min−1
and a mass median aerodynamic diameter of 4.5 μm as
previously described [36]. Sputum samples will be visu-
ally separated from the saliva and divided into 2 aliquots.
One aliquot will be spread over a glass slide, to be fixed
and stained with Diff Quick (Sigma-Aldrich, São Paulo,
Brazil). The second aliquot will be treated with 0.1% of
dithiothreitol (Sigma-Aldrich, USA) and stirred using a
vortex mixer for total and differential cell counts. The
total cell counts will be performed using a Neubauer
chamber, and the cell suspension will be adjusted to
1.0 × 106.mL−1. Differential cells counts will be classi-
fied as eosinophils, lymphocytes, neutrophils, macro-
phages, squamous cells, goblet cells, and ciliated cells
on the basis of their morphology by a single-blinded
investigator.
FENO will be measured according to the ATS/ERS guide-
lines (2011) [37]. Briefly, patient’s will be asked to blow
into a Mylar bag, (keeping the expiratory pressure at the
mouth at 12 cm H2O to avoid air contamination from
the nasal cavity). Exhaled air will be filtrated before
being collected into the bag, and the expiratory pressure
achieved by the individual will monitored by a manom-
eter. All collected samples will be mixed 10 s before the
determination of NO concentration by chemilumines-
cence (Sievers 280 NOA; Sievers Instruments, USA) and
analyzed up to 24 h after sample collection. The equip-
ment will be calibrated before each analysis.
Systemic inflammation It will be quantified in 15 mL
of blood sample obtained at rest. Patients will be advised
to fast for at least 8 hours not carry out physical activity
and not ingest alcoholic and/or caffeinated beverages for
24 hours before the blood collection. Blood samples will
be centrifuged at 1800 rpm for 10 minutes at 0°C and
will be stored at -70°C. Th1 (IL-6, TNF), Th2 (IL-4, IL-5,
and IL-13), and anti-inflammatory (IL-10 e IL-1ra) cyto-
kines as well as osteopontin will be quantified in dupli-
cate by using commercial cytometric bead array kits
(BD Biosciences, USA). Serum levels of cortisol will be
analyzed by fluoroimmunoassay using the AutoDelfia
system (Wallac, Finland).
Additional measures
To appropriately describe our patients, we will collect
basic demographic and medical information including age,
smoking status, ethnicity, gender role and anthropometrics
(height and weight). It will also be collected self-reported
details of current and lifetime history of diagnosis of
asthma, other respiratory diseases, cardiovascular disease
risk factors, cancers, auto-immune diseases, and all cur-
rent medications. All reported clinical data will be verified
by a hospital medical record review.
Data analysis
Sample size
It was estimated based on a minimal important differ-
ence of 0.5 points on the ACQ questionnaire with a
standard deviation of 0.72 [38]. A sample size of 40
patients was required for a 5% level of significance with
80% power using a two-tailed t test. An estimated drop-
out rate of 20% was used to determine the final target
sample size of 48 patients.
Proposed statistical analyses
Data normality will be evaluated with the Kolmogorov-
Smirnov test. The comparison of the clinical control and
other variables will be made by a two-way analysis of
variance (ANOVA) with repeated measures followed by
the Student-Newman Keuls post-hoc test to identify
significant differences. The level of statistical significance
will be set at 5% (p < 0.05).
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Analyses population and missing data
All main analyses will use intention-to-treat, considering
all patients as randomized regardless of their adherence to
the treatment protocol or completion of post-intervention
assessments. These analyses will be used to define the
efficacy of aerobic and breathing exercises to influence
asthma control.
Discussion
Asthma symptoms have a significant impact on patient’s
life and the proper clinical treatment is very important
to reduce those symptoms; however, sometimes clinical
control is difficult, despite the appropriate amount of
prescribed medication. Aerobic and breathing exercises
have been considered important as complementary
therapies in addition to the pharmacological treatment
mainly for patients with controlled or partially con-
trolled asthma, because they improve disease control
[1]. In addition, asthmatic patients have 2 main clinical
conditions that support the importance of these non-
pharmacological interventions: they are more prone to
be physically deconditioned compared with their peers
and they also have a high prevalence of hyperventilation
symptoms [39]. Because of that, asthmatic patients tend
to face more negative attitudes toward exercise and
present higher levels of anxiety and depression [40,41].
The proposal of our study, comparing the benefits of
aerobic and breathing exercises training on clinical
control, seems quite relevant because even if both
techniques have similar effects in reducing asthma
symptoms, we will further investigate some mecha-
nisms in order to understand how patients develop
their benefits at each and every intervention. There is
evidence that aerobic exercises improve cardiovascular
fitness, resistance to stress and health related quality of
life (HRQoL) as well as decrease dyspnea, incidence of
exercise-induced bronchospasm, use of corticoste-
roids, inflammatory parameters, anxiety and depres-
sion related to asthma [9]. A recent Cochrane review
confirmed these benefits and also demonstrated that
physical training can be well tolerated among people
with asthma [42]. These studies show us that there was
some evidence to suggest that physical training may
have positive effects on HRQoL. Therefore, exercise
training can also improve daily living physical activity
and reduce dyspnea [43]. In our opinion, the improve-
ment in aerobic capacity will reduce airway inflamma-
tion levels improving clinical control.
In addition, the practice of breathing exercises have
been shown to improve HRQoL, peak expiratory flow,
asthma symptoms as well as to reduce the levels of
hyperventilation symptoms, anxiety and depression and
medication consumption [44]. A recent Cochrane review
demonstrated that individual trials reported positive
effects of breathing exercises, but authors concluded
that no reliable conclusions could be drawn concerning
the use of breathing exercises in asthma control [10]. In
our opinion, breathing exercise will reduce anxiety and
depression levels, which seem to be associated with
dysfunctional breathing such as hyperventilation [16]
normalizing, thus, the autonomic system [45].
Although the benefits of breathing and aerobic exer-
cises have been extensively investigated, the comparison
between both interventions has never been performed.
Then, this study will be the first to make this compari-
son and to investigate several physiological mechanisms
which may be triggered either by aerobic training or by
breathing exercises. Furthermore, the findings of our
results will allow us to understand its application and
suitability to patients that will have more benefits for
every intervention optimizing its effect.
Study status
We declare that the study in is ongoing and we are still
analyzing data.
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